title: Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.
authors: Manuel Cappellari, Stroke Unit, Division of Neurology, Department of Neuroscience, Azienda Ospedaliera Univarsitaria Integrata, iazzale A. Stefani 1, 37126 Verona, Italy, Tel.: +39 3397978357, Fax: +30 0458122804, E-mail: manuel_cappellari@libero.it.
authors: M
authors: M
authors: Cappellari
authors: P
authors: P
authors: Bovi
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors; D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D000075202:Contraindications; D000069604:Dabigatran / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004347:Drug Interactions; D057510:Endovascular Procedures; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D011728:Pyridones / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies; D000069552:Rivaroxaban / Q000009:adverse effects* / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy*; D017131:Thrombectomy; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D000069552:Rivaroxaban; D010959:Tissue Plasminogen Activator; D000069604:Dabigatran